Insiders · Profile

Mehta Vimal

CEO and President at BioXcel Therapeutics. Filing since 12 Mar 2018. CIK 0001733369

Company
Date
Role
Action
Shares
Amount
Of holding
20 May 2026
CEO and President
Sold on a plan
19,419
$21.11K
21.8%
16 Dec 2024
CEO and President
Sold on a plan
3,117
$1.13K
5.0%
16 Sep 2024
CEO and President
Sold on a plan
1,982
$1.37K
3.7%
17 Jun 2024
CEO and President
Sold on a plan
2,134
$2.74K
4.3%
5 Jun 2024
CEO and President
Sold at will
409,136
$199.62K
100%
4 Jun 2024
CEO and President
Sold at will
1,018,358
$205.52K
78.2%
4 Apr 2024
CEO and President
Sold on a plan
5,268
$13.82K
10.8%
16 Jun 2023
CEO and President
Sold on a plan
30,000
$605.50K
42.9%
15 Jun 2023
CEO and President
Sold on a plan
30,000
$646.23K
42.9%
22 May 2023
CEO and President
Sold on a plan
6,500
$167.64K
14.8%
21 Mar 2023
CEO and President
Sold at will
30,000
$591.41K
65.4%
20 Mar 2023
CEO and President
Sold at will
34,500
$631.91K
68.5%
16 Dec 2022
CEO and President
Sold, plan not stated
30,000
$583.32K
75.1%
15 Dec 2022
CEO and President
Sold, plan not stated
30,000
$598.18K
75.1%
25 Jun 2021
CEO, President and Secretary
Sold, plan not stated
473,250
$14.59M
5.2%
16 Aug 2019
CEO, President and Secretary
Bought
974
$8.66K
10.8%
15 Aug 2019
CEO, President & Secretary
Bought
2,625
$22.76K
41.3%
14 Aug 2019
CEO, President & Secretary
Bought
358
$3.02K
6.0%
13 Aug 2019
CEO, President & Secretary
Bought
1,000
$8.75K
20.0%
14 Dec 2018
CEO, President, Secretary
Bought
2,000
$8.77K
66.7%
4 Dec 2018
CEO, President, Secretary
Bought
1,000
$5.12K
50.0%
3 Dec 2018
CEO, President, Secretary
Bought
1,000
$5.17K
100%
30 Nov 2018
CEO, President, Secretary
Bought
1,000
$5.10K
opened
12 Mar 2018
CEO, President and Secretary
Bought
2,000
$22.00K
opened
24 decisions on file.